Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
Clinical trial NCT06989723 · RECRUITING
Trial details
- NCT number
- NCT06989723
- Sponsor
- Seoul National University Bundang Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2026-12-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.